BioBridgeXAll companies

Aktis Oncology, Inc.

Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: AKTS

Aktis Oncology, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2020. Its shares trade on Nasdaq under the ticker AKTS. It has reported private securities offerings to the US SEC, most recently $175 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Aktis Oncology at a glance

Typepharmaceutical company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2020
Stock listingNasdaq: AKTS
SEC industryPharmaceutical Preparations
SEC CIK2035832

What does Aktis Oncology do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $175 million sold (2024).

Frequently asked questions about Aktis Oncology

Where is Aktis Oncology headquartered?

Aktis Oncology, Inc. is headquartered in Boston, Massachusetts, United States.

What does Aktis Oncology do?

Aktis Oncology, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Aktis Oncology a public company?

Yes. Aktis Oncology, Inc. trades on Nasdaq under the ticker AKTS.

When was Aktis Oncology founded?

The earliest incorporation on record for Aktis Oncology, Inc. is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.